Defensins are an important component of the innate immune system of ticks. These small peptides are produced by various genera of ticks, and expressed in various tissues. In this study we used RNA interference to silence the expression of the defensin varisin produced by the hemocytes of the American dog tick, Dermacentor variabilis. Ticks were injected with double stranded varisin RNA prior to being placed on a rabbit. After feeding, the ticks were removed, bled, and the hemolymph plasma and hemocytes separated. Hemocytes were screened for the presence (or absence) of both varisin transcript and peptide. Varisin peptide was below detectable levels and the transcript showed a greater than 99% knockdown. The antimicrobial activity of the hemolymph plasma was reduced 2-4 fold compared to that of control injected ticks indicating varisin accounts for a large portion of the antimicrobial activity of the hemolymph.
Introduction
Ticks are obligate blood-feeding ectoparasites that have the ability to transmit a wide variety of disease causing microbes. In fact, they have the ability to transmit more disease causing microbes than any other blood feeding arthropod, including mosquitoes, although more human illness is caused by mosquito-borne agents than by tick-borne ones. The hard tick Dermacentor variabilis (American dog tick) can be found throughout the southeastern USA, and up the east coast to Nova Scotia, Canada (Brown et al. 2005) . This hard tick is a vector of the pathogens responsible for Rocky Mountain Spotted Fever (RMSF), human monocytotrophic ehrlichiosis (HME), tularemia, and is capable of causing tick paralysis. However, ticks are more than 'syringes-on-legs'. Although lacking the highly developed, adaptive immune response found in vertebrates, ticks have an eYcient innate immune response. The 1 C innate immune system consists of both cellular and soluble components (Gillespie et al. 1997; Schmid-Hempel 2005; Taylor 2006 ) that are eVective in eliminating many microbes. The cellular responses include phagocytosis, nodulation, and encapsulation (Eggenberger et al. 1990; Inoue et al. 2001; Ceraul et al. 2002; Taylor 2006; Sonenshine and Hynes 2008) . The soluble aspects of the innate immune response include production of antimicrobial peptides, including defensins (Bulet et al. 2003; Taylor 2006; Sonenshine and Hynes 2008) .
Invertebrates produce many diVerent types of antimicrobial molecules when challenged by microbes or parasites (Cociancich et al. 1994; Bulet et al. 2003; Taylor 2006; Tsuji et al. 2007; Sonenshine and Hynes 2008) . Among the most conserved of these molecules are the defensins. Defensins are small cationic peptides, generally comprising 34-61 amino acids for the mature peptide (3-6 kDa), produced by organisms from plants to invertebrates to the most complex mammals (Bulet et al. 2003; Sonenshine and Hynes 2008) . Insect defensins generally have six cysteine residues that form three disulWde bridges with linkages between Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6 (Bulet et al. 1999 (Bulet et al. , 2003 Taylor 2006) ; the exception being drosomycin, produced by Drosophila melanogaster which has four disulWde bonds and antifungal activity (Michaut et al. 1996; Bulet et al. 2003) . Most insect defensins are active against gram positive bacteria, with some showing activity against other microbial challengers such as gram negative bacteria, parasites and fungi (Cociancich et al. 1994) . To date, more than 20 defensins have been identiWed from 11 species of tick (Taylor 2006; Sonenshine and Hynes 2008) . Defensins are produced as a prepro form, which is cleaved, at a highly conserved RVRR site, to release the mature peptide . Some species of tick have multiple isoforms of defensin, with Ornithodoros moubata having four isoforms (Nakajima et al. 2001 (Nakajima et al. , 2002 and I. ricinus having two isoforms (Rudenko et al. 2007) , while others appear to have only one form Todd et al. 2007 ). The Wrst defensin recognized from a hard tick was varisin, isolated from the hemolymph of American dog tick, Dermacentor variabilis (Johns et al. 2001a, b) . The transcript sequence of varisin was determined following RT-PCR from RNA isolated from hemocytes (Ceraul et al. 2003 ). It appears that varisin is produced in the hemocytes and released into the hemolymph following microbial challenge. Although transcript has been detected in various tissues Sonenshine et al. 2005; Ceraul et al. 2007 ) the peptide has only been detected in the hemolymph/hemocytes. Recently a second defensin has been reported from D. variabilis which had less than 50% similarity to varisin (Ceraul et al. 2007) . In order to understand the role of varisin in the innate immune system of D. variabilis, the expression of the varisin gene was silenced using RNA interference (RNAi). RNAi has been used to study gene function in ticks due to the lack of other means of genetic manipulation (de la Fuente et al. 2005 Fuente et al. , 2007 . In this study we show that RNAi can be used to silence the gene for varisin and that silencing results in a decreased level of antimicrobial activity of tick hemolymph.
Materials and methods

Ticks, injection, and bleeding
Dermacentor variabilis were obtained from a colony maintained at Old Dominion University as previously described (Johns et al. 1998 (Johns et al. , 2001a . All use of animals in this research was done in accordance with protocols approved by the Old Dominion University Institutional Animal Use and Care Committee. Unfed virgin female ticks were injected with 1-5 l of 1 C double stranded RNA (dsRNA), or Shen's solution (Oliver et al. 1974 ) for the controls, using a 30 gauge £ ½" hypodermic needle attached to a 10 l Hamilton syringe. Injection was via the foramen between the capitulum and anterior end of the scutum. After injection, the needle was held in the tick's body for 30 min to prevent leakage of the injected material. Subsequently, the ticks were conWned within plastic capsules attached to New Zealand white rabbits (Oryctolagus cuniculus). After feeding for 5 days the ticks were forcibly removed from the rabbit and hemolymph was collected by severing the forelegs at the coxal-trochanteral joint and applying gentle pressure to the body. The clear, amber-colored liquid expressed was collected in a glass micropipette and put into either 20 l Shen's saline solution or 100 l RNA later (Applied Biosystems, Foster City, CA) depending on the assay; Shen's for protein and antimicrobial assays, RNA later for RT-PCR reactions. Approximately the same number of ticks were used for both control and test injections.
Previous results have suggested storage of varisin in the hemocytes which is released on challenge (Ceraul et al. 2003) . Stored varisin should be released on injection of the dsRNA. To show that no new varisin was made and stored after injection of the dsRNA, some ticks were pin-pricked (wounded) and allowed to incubate for 1 h prior to bleeding. Double stranded RNA production Double-stranded RNA was prepared from a PCR product, containing the entire 624 bp cDNA fragment of varisin derived from D. variabilis hemocytes (Ceraul et al. 2003) , using the MEGAscript RNAi kit (Applied Biosystems). The gene was ampliWed from a plasmid using the primers DEFT75: 5Ј-TAATACGACTCACTATAGGGTACTATGCGCGGACTTTGCATCTGC and DEFT733: 5Ј-TAATACGACTCACTATAGGGTACTTACGTCGACAAAGCGCTTCGG, which contain the T7 promoter for in vitro transcription (shown in italics). AmpliWcation was carried out using the following cycle parameters: 94°C for 2 min, followed by 35 cycles of 94°C for 30 s and 68°C for 1 min; 68°C for 7 min completed the run. The PCR fragment was then used in the transcription reaction as described by the manufacturer. After transcription, the reaction was treated to remove DNA and single stranded RNA, then puriWed, and ethanol precipitated. The dsRNA was then resuspended in Shen's solution for injection into ticks. Ticks were injected with 10 11 -10 12 molecules of dsRNA as described above. Control ticks were injected with the same volume of Shen's solution.
Quantitative RT-PCR Using the "illustra QuickPrep Micro mRNA puriWcation kit" (GE Healthcare, NJ) the mRNA was isolated from hemolymph collected in RNA-later. The isolated mRNA was then treated with Turbo DNA-free (Applied Biosystems) to remove any residual DNA; this step was repeated if necessary. Reverse transcription reactions were carried out using the ImProm-II Reverse Transcription System in the presence of RNasin according to the manufacturer's instructions (Promega Corp, Madison, WI) using either Oligo(dT) or random hexamer primers. The synthesized cDNA was then used in real-time PCR reactions. Controls, in which reverse transcriptase was not added, were set up for each reaction to ensure no DNA contamination.
Real-time PCR
Real-time PCR was carried out using the RT 2 SYBR Green qPCR Master Mix (SuperArray Bioscience Corporation, Frederick, MD) on a Cepheid Smartcycler (Cepheid, Sunnyvale, 1 C CA). Control real-time reactions were set up monitoring actin expression using 0.2 M Wnal concentration of actF (5Ј-GTACGCCAACACCGTTCTC-3Ј) and actR (5Ј-ATCTT GATCTTCATGGTGGAA-3Ј) primers. Reactions for the detection of varisin were 0.2 M vsnF (5Ј-ATGCGCGGACTTTGCATCT-3Ј) and vsnR (5Ј-TTAATTCCTGTAGCAGGTG CA-3Ј). The cDNA template (1 l) was added last to the 25 l reaction. All reactions were run on the same program: 95°C for 60 s then 40 cycles of 95°C for 15 s, 60°C for 60 s, and followed by a melt curve. C T values were determined and used either in the comparative C T method ( C T ) for relative quantiWcation, or to determine the actual number of molecules based on a standard curve derived from adding known amounts of ampliWed DNA to a set of real-time reactions. Controls without reverse transcriptase and without template were set up with each set of samples.
Protein gels
Hemolymph collected in Shen's solution was used to check for the presence or absence of the varisin band in both hemolymph plasma and hemocyte lysate. Hemocytes were collected from the hemolymph by centrifugation at 1,000 £ g for 20 min at 4°C. The pellet was resuspended in 10 l water and frozen until needed. Cells were thawed and 4 l of the hemocytes were mixed with loading buVer and reducing agent, then heated at 70°C for 10 min before loading on a 4-12% NuPAGE Tris-Bis SDS gel (Invitrogen) with See Blue molecular weight marker (Invitrogen). After electrophoresis at 200 V for 35 min, the gel was silver stained using the Silver Express staining kit (Invitrogen). A western blot analysis of a similarly run gel was carried out as previously described (Ceraul et al. 2003) except that the primary antibody (anti-varisin) was diluted 1:50.
Antimicrobial assay
Antimicrobial activity of hemolymph plasma was assessed using a well diVusion assay. Samples (10 l) to be tested were pipetted into 4 mm diameter wells cut into tryptic soy agar plates, then allowed to dry, exposed to chloroform vapors for 20 min, and aired. An overnight culture of the gram positive bacterium Micrococcus luteus was seeded onto the surface of the plate using a sterile swab, and the plate incubated at 37°C overnight. Zones of inhibition were seen as areas of no growth around the wells. Two fold dilution series were carried out using 0.9% saline as the diluent. The titer (arbitrary units, AU) was determined as the last dilution to show a zone of growth inhibition.
Results
Antimicrobial assay
Screening of undiluted hemolymph plasma for antimicrobial activity against the sensitive gram positive bacteria M. luteus indicated less activity in the dsRNA treated tick hemolymph, than in the ticks injected with Shen's solution (Fig. 1) . When the hemolymph was two-fold serially diluted, titers for the control (Shen's injected) were 2-4 times higher than the test (dsRNA injected) sample. Control titers were 8-16 AU whereas the dsRNA injected tick hemolymph was 4 AU.
C
Loss of varisin peptide in hemolymph plasma and cells
Cell lysate and hemolymph plasma were visualized on a polyacrylamide gel, stained for protein. A representative gel of tick hemolymph plasma is shown in Fig. 2a . The varisin peptide band is missing, or very faint, in the hemolymph plasma of those ticks treated with dsRNA, while those treated with buVer still show the presence of a varisin-sized band. The same eVect was seen with hemocyte extracts, in that the varisin band is present in the hemocytes of control ticks but not those injected with the dsRNA construct (not shown). Western blot analysis using the anti-varisin antibody conWrmed the loss of the defensin in both hemolymph plasma (Fig. 2b) and hemocytes (not shown). The presence of multiple bands in the western blot is most likely due to the non-speciWc binding of antibodies to other tick proteins as previously described (Ceraul et al. 2003) .
To detect release of the varisin peptide following a wounding response, ticks were also wounded 1 h prior to bleeding and collecting the hemolymph. Figure 2 shows that the 
Real-time PCR assays
Real-time PCR was used to determine the degree to which varisin transcription was silenced in treated ticks. Representative results are shown in Fig. 3 . Treatment with dsRNA results in a decrease in the amount of varisin transcript as seen by the number of cycles required for the transcript to be detected. Figure 3 shows control and treated samples ampliWed using the varisin primers. The insert shows the graphs of control and treated reactions with the actin ampliWcation; this ensures equal amounts of template were added to the reaction. The eVect of treatment can easily be seen in this graph but to gain insight into how much the gene is silenced in our samples we determined the amount of transcript remaining using both the relative quantiWcation and standard curve methodologies. A standard curve was prepared in which the C T was plotted against the number of molecules present; we used ten-fold dilutions from 10 9 through 10 3 copies of the varisin gene. Using the standard curve to determine the number of molecules of varisin, we found that injection of dsRNA for varisin resulted in a 99-99.5% knockdown. Using the C T method for relative quantiWcation treatment with dsRNA the knockdown was as high as 99.9%. These results show that injection of varisin dsRNA eVectively silences the expression of the varisin gene.
Discussion
RNA interference is an eVective way of examining gene function in ticks, and has been used to target a number of diVerent genes (de la Fuente et al. 2007; Karim et al. 2008) . We can now add to this list varisin, which we believe to be the major defensin in tick hemolymph. Inactivation of 
C
varisin results in a 2-4 fold reduction in the antimicrobial activity of tick hemolymph as determined by our plate assays. However, it does not account for all the inhibitory activity since hemolymph plasma from the treated ticks was still able to inhibit the growth of M. luteus. Micrococcus luteus was chosen as an indicator of antimicrobial activity because it is sensitive to and used for detecting activity of numerous antimicrobial agents. We currently do not know the antibacterial spectrum of activity (Gram positive, gram negative or fungi) of the varisin peptide but M. luteus is very sensitive to the action of the peptide. What accounts for the other antimicrobial activity seen in the hemolymph? Perhaps the most likely candidate is lysozyme, which is known to be expressed by D. variabilis hemocytes (Simser et al. 2004; Ceraul et al. 2007 ) and possibly released into the hemolymph plasma fraction. We have previously shown that a lysozyme is able to enhance the antimicrobial activity of varisin (Johns et al. 2001a, b) . Whether authentic tick lysozyme functions with varisin in the same manner as the egg white lysozyme remains to be determined. What would happen to the antimicrobial titer of tick hemolymph if we silenced lysozyme expression as well as varisin? RNAi studies into this aspect are currently underway in our laboratory.
There are a number of other antimicrobial molecules present in tick hemolymph Taylor 2006 ) that could also result inhibition of microbial growth. Activity of these other molecules would be indicated by a smaller zone of inhibition as shown in Fig. 1 . One possible peptide that could be responsible for some activity would be the second defensin reported from D. variabilis, defensin-2 (Ceraul et al. 2007 ). However, this is an unlikely player in the antimicrobial activity of hemolymph since it is expressed by the midgut and not expressed by hemocytes.
Defensins have been implicated as major players in the innate immune response of ticks. We have shown that RNAi can be used to target and silence varisin expression in hemocytes and therefore in hemolymph. We have previously reported that varisin was most likely produced and stored in the hemocytes (Ceraul et al. 2003 ) then released into the hemolymph upon wounding or following microbial challenge. New defensin would then be made at a later time . In this study, the initial challenge would be the injection of dsRNA into the hemocoel, resulting in release of the stored defensin. Varisin released at the time of dsRNA injection would be expected to have been lost from the tick within 24 h (Johns 2003 ). Since we do not detect varisin in the hemocytes or released into the hemolymph, even after another wounding (Fig. 2) , it appears that RNAi eVectively prevents synthesis of any new varisin. Whether inhibition of varisin production has an eVect on the tick, beyond that of its role in the innate immune response is unknown. What, if any, additional or alternative roles varisin has in tick immunity requires further investigation, since defensin has been suggested to have an alternative function in mosquito immunity (Bartholomay et al. 2004) . Similarly, we do not know what is the actual in vivo eVect of varisin silencing. In a separate study reported elsewhere in this issue (Kocan et al. 2008) , RNAi silencing of varisin in male D. variabilis resulted in a reduction of Anaplasma marginale infections as well as morphological changes in the colonies of these rickettsiae in the tick midgut.
